BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 19685823)

  • 21. Hepatitis B and C infection in first-time blood donors in Karachi--a possible subgroup for sentinel surveillance.
    Abdul Mujeeb S; Nanan D; Sabir S; Altaf A; Kadir M
    East Mediterr Health J; 2006 Nov; 12(6):735-41. PubMed ID: 17333817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
    Li F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B; Meriç M; Willke A
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
    Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco].
    Zohoun A; Hadef R; Zahid H; Benkirane M
    Med Trop (Mars); 2011 Oct; 71(5):513-4. PubMed ID: 22235634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
    Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
    Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
    Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
    East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
    Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
    QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B and C infection markers among adult women in urban and rural areas in Shaanxi Province, China.
    Shimbo S; Zhang ZW; Gao WP; Hu ZH; Qu JB; Watanabe T; Nakatsuka H; Matsuda-Inokuchi N; Higashikawa K; Ikeda M
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):263-8. PubMed ID: 9886109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of positive markers for hepatitis B (HBV Ags) and hepatitis C (Anti-HCV) in health personnel at the Social Security Institute of Mexico State and Municipalities].
    González-Huezo MS; Sánchez-Hernández E; Camacho MC; Mejia-López MD; Rebollo-Vargas J
    Rev Gastroenterol Mex; 2010; 75(3):293-8. PubMed ID: 20959179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study.
    Guennoc X; Narbonne V; Jousse-Joulin S; Devauchelle-Pensec V; Dougados M; Daurès JP; Saraux A
    J Rheumatol; 2009 Jul; 36(7):1407-13. PubMed ID: 19531755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Seroprevalence of the infection and risk factors of hepatitis B and C in healthy military personnel].
    Chacaltana A; Espinoza J
    Rev Gastroenterol Peru; 2008; 28(3):217-25. PubMed ID: 18958136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic.
    Haidar NA
    Saudi Med J; 2002 Sep; 23(9):1090-4. PubMed ID: 12370719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiological and clinical significance of hepatitis B and C marker detection in blood of patients and donors].
    Pavlov AI; Khazanov AI; Beliakin SA; Pliusnin SV
    Voen Med Zh; 2010 Nov; 331(11):31-6. PubMed ID: 21395157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors].
    Rivera-López MR; Zavala-Méndez C; Arenas-Esqueda A
    Gac Med Mex; 2004; 140(6):657-60. PubMed ID: 15633577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.